"Famotidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Descriptor ID |
D015738
|
| MeSH Number(s) |
D02.886.675.215 D03.383.129.708.215
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Famotidine".
Below are MeSH descriptors whose meaning is more specific than "Famotidine".
This graph shows the total number of publications written about "Famotidine" by people in this website by year, and whether "Famotidine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Famotidine" by people in Profiles.
-
Kamal F, Khan MA, Sharma S, Imam Z, Howden CW. Lack of Consistent Associations Between Pharmacologic Gastric Acid Suppression and Adverse Outcomes in Patients With Coronavirus Disease 2019: Meta-Analysis of Observational Studies. Gastroenterology. 2021 06; 160(7):2588-2590.e7.
-
Smolarz BG, Ross J, Sachinwalla E, Marcus A, Abazia DT. Noncardiogenic pulmonary edema in a patient receiving vancomycin and oxycodone-acetaminophen. Ann Allergy Asthma Immunol. 2008 Jun; 100(6):623-4.
-
Roth EJ, Plastaras CT, Mullin MS, Fillmore J, Moses ML. A simple institutional educational intervention to decrease use of selected expensive medications. Arch Phys Med Rehabil. 2001 May; 82(5):633-6.